您的购物车当前为空
MAGE A4 (230-239) 是一种来源于MAGE-A4蛋白的特定肽段。它具有免疫原性,能够激活T细胞,从而攻击表达此MAGE-A4蛋白的肿瘤细胞。目前,MAGE A4 (230-239) 正在用于开发新一代基于T细胞的免疫治疗方法。

MAGE A4 (230-239) 是一种来源于MAGE-A4蛋白的特定肽段。它具有免疫原性,能够激活T细胞,从而攻击表达此MAGE-A4蛋白的肿瘤细胞。目前,MAGE A4 (230-239) 正在用于开发新一代基于T细胞的免疫治疗方法。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. This immunogenic epitope has the capability to activate T cells and induce cytotoxic responses against tumor cells expressing MAGE-A4. MAGE A4 (230-239) is utilized in developing next-generation T-cell-based immunotherapies. |
| 分子量 | 1132.18 |
| 分子式 | C48H73N15O17 |
| CAS No. | 252875-61-9 |
| Sequence | Gly-Val-Tyr-Asp-Gly-Arg-Glu-His-Thr-Val |
| Sequence Short | GVYDGREHTV |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容